Pfizer PFE Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $62.58B-1.6% | $63.63B+6.8% | $59.55B-41.1% | $101.18B+24.5% | ||
| $16.07B-10.0% | $17.85B-28.5% | $24.96B-27.3% | $34.34B+11.4% | ||
| $46.51B+1.6% | $45.78B+32.3% | $34.6B-48.2% | $66.83B+32.4% | ||
| 74.3%+2.4pp | 71.9%+13.8pp | 58.1%-8.0pp | 66.1%+4.0pp | ||
| $13.79B-6.4% | $14.73B-0.3% | $14.77B+8.0% | $13.68B+7.7% | ||
| —— | $8.03B— | —— | $34.73B+42.9% | ||
| -$266M-850% | -$28M+97.5% | -$1.12B-134% | $3.33B+79.7% | ||
| —— | $8.03B— | —— | $31.37B+42.7% | ||
| —— | $1.41— | —— | $5.48+42.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pfizer's revenue?
- Pfizer (PFE) generated $63.3B in revenue over the trailing twelve months, up 1.4% year over year.
- Is Pfizer profitable?
- Pfizer reported $12.1B in net income over the trailing twelve months, a 15.7% net margin.
- What is Pfizer's earnings per share?
- Pfizer's diluted EPS over the trailing twelve months is $2.12.
- Where does Pfizer's income statement data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
